Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.

MLA

Carrascosa, J. M., et al. “Body Mass Index in Patients with Moderate-to-Severe Psoriasis in Spain and Its Impact as an Independent Risk Factor for Therapy Withdrawal: Results of the Biobadaderm Registry.” Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 28, no. 7, July 2014, pp. 907–14. EBSCOhost, https://doi.org/10.1111/jdv.12208.

APA

Carrascosa, J. M., Vilavella, M., Garcia-Doval, I., Carretero, G., Vanaclocha, F., Daudén, E., Gómez-García, F. J., Herrera-Ceballos, E., De la Cueva Dobao, P., Belinchón, I., Sánchez-Carazo, J. L., Alsina, M., López-Estebaranz, J. L., Ferrán, M., Peral, F., Torrado, R., Rivera, R., Jiménez-Puya, R., Mendiola, M. V., & Ferrándiz, C. (2014). Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. Journal of the European Academy of Dermatology and Venereology : JEADV, 28(7), 907–914. https://doi.org/10.1111/jdv.12208

Chicago

Carrascosa, J M, M Vilavella, I Garcia-Doval, G Carretero, F Vanaclocha, E Daudén, F J Gómez-García, et al. 2014. “Body Mass Index in Patients with Moderate-to-Severe Psoriasis in Spain and Its Impact as an Independent Risk Factor for Therapy Withdrawal: Results of the Biobadaderm Registry.” Journal of the European Academy of Dermatology and Venereology : JEADV 28 (7): 907–14. doi:10.1111/jdv.12208.